In KRAS-mutated lung cancer, there is a synergic effect of STK11/LKB1 and KEAP1 loss: STK11/LKB1 loss results in an increased level of ROS and high redox stress with an inability to maintain ATP levels. Here, KRAS is linked to lung cancer.